Recon: FDA staff indicates support for Bluebird gene therapy; FDA expert panel reviews Novavax vaccine

ReconReconBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy